Anlotinib plus oral fluoropyrimidine S-1 in refractory or relapsed small-cell lung cancer (SALTER TRIAL): a multicenter, single-arm, phase II trial
Wang, Wei, Wu, Guixian, Luo, Wujun, Lin, Ling, Zhou, Chao, Yao, Guifei, Chen, Meifang, Wu, Xiaomai, Chen, Ziran, Ye, Junhui, Yang, Haihua, Lv, Dongqing
Published in BMC cancer (27.09.2024)
Published in BMC cancer (27.09.2024)
Get full text
Journal Article